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ORIGINAL ARTICLE

Advances in Exercise, Physical Activity,
and Diabetes Mellitus
Sepideh Mohajeri and Michael C. Riddell

Introduction

M

ore and more evidence suggests that regular
exercise is the single best lifestyle tool to prevent,
delay, or treat diabetes. Emerging research is allowing clinicians and patients to choose the best forms of exercise and
helping us all understand the mechanisms for why exercise is
so beneficial. Motivating patients to be more physically active and outlining strategies to help prevent exercise-associated hypoglycemia in type 1 diabetes remain the two most
challenging aspects of the physical activity prescription. This
year, we highlight eight leading peer-reviewed original articles on exercise, physical activity, and diabetes that were
published in the period July 1, 2013, to June 30, 2014. From
the emergence of exercise smart pumps to the importance of
postmeal walking, this selective review covers some of the
key advances made over the past year.
Blood glucose responses to type, intensity,
duration, and timing of exercise
Colberg SR 1, Hernandez MJ 2, Shahzad F 2

1

Old Dominion University, Norfolk, VA;
and 2Diabetes Hands Foundation, Berkeley, CA
Diabetes Care 2013; 36: e177

Background and Rationale
To encourage involvement in regular exercise in the
management of diabetes, the Diabetes Hands Foundation
initiated the online Big Blue Test (BBT) data collection
program. During the BBT, individuals with diabetes partake
in physical activity and record blood glucose (BG) levels
with the hopes of raising awareness regarding the benefits of
exercise. This study uses data from the 2012 BBT to assess
how various parameters of exercise (type, intensity, duration,
and time since last meal) impact glycemia.
Methods
A total of 5,157 individuals with diabetes, of which approximately 90% administered insulin, used an iPhone app or

the BBT website to report their category of exercise, and BG
values prior to and immediately following ‡1 physical activity session(s). Different forms of exercise were determined
by looking at a past BBT event. Reported categories included
exercise type (walking, running/jogging, cycling, conditioning machines, dancing, nonspecified), intensity (moderate
or vigorous), duration (£10, 11–19, 20–29, or ‡30 min), and
the amount of time passed since previous meal ingestion
(30 min, 1, 2, or ‡3 h).
Results
In order from most to least popular, participants reported
engaging in the following activities: walking (48.5%), nonspecified (18.7%), running/jogging (11.9%), cycling (8.8%),
conditioning machines (6.4%), and dancing (5.7%). These
activities and other types of exercise promoted decreases
(75.8% of cases) and increases (15.4%), or resulted in unchanged (8.8%) BG levels. The smallest decrease in BG
was seen with walking (-25.0 – 42.4 mg/dL), while the
largest change was observed with cycling activities (- 42.4 –
48.8 mg/dL). Interestingly, moderate forms of exercise decreased BG levels (- 32.7 – 44.1 mg/dL) more than vigorous
activity (-28.0 – 53.6 mg/dL). Exercise of longer duration
led to a greater reduction in BG when all exercise intensities
were combined, and with moderate intensity alone, but not
with vigorous exercise intensity alone. The greatest decrease
in BG occurred when exercise was completed 1 or 2 h after a
meal (similar decline in both periods), when compared with
30 min or ‡ 3 h postmeal.
Discussion
Engaging in various types, durations, and intensities of
exercise, at different postprandial time points, can all impact
the glucose response. While exercise generally decreases
BG, high-intensity exercise-associated counterregulatory
hormones can help to prevent hypoglycemia or may even
cause glucose to rise (1). As such, individuals with type 1
diabetes may find it beneficial to incorporate a 10 s sprint
before or after moderate activity to help limit the drop in
glycemia. Longer bouts of exercise increase the likelihood of

School of Kinesiology and Health Science, York University, Toronto, ON, Canada.
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low BG (2), making it necessary to be well-prepared to treat
hypoglycemia. Finally, when planning an exercise session, it
can be beneficial to consider the length of time that has passed
since a meal to optimize the desired decrease in BG, or to
better avoid the risk of postexercise hypoglycemia.
Comment
As a part of a healthy lifestyle, individuals with diabetes
can engage in a variety physical activity modalities.
However, predicting the BG response to exercise is not
always easy. This article shows that there is no single
response to exercise; many variables can be manipulated
to achieve the desired glycemic response from an exercise session. A basic understanding of how different
types of moderate and vigorous forms of exercise can
impact BG levels based on this large database should
help individuals anticipate their body’s reaction and
therefore better plan treatments or schedule exercise
sessions. While the results of this article are based on
self-reported data, providing in-depth information regarding responses to exercise type, duration, intensity,
and time can help clinicians to provide accurate exercise
prescriptions. Also based on this data set, it appears that
insulin users have much more of a drop in glycemia with
most forms of exercise compared with nonusers (3).
Physicians can use this information to better utilize
physical activity as a viable therapeutic option for high
blood glucose in patients with diabetes.
Reduced hypoglycemia and increased time
in target using closed-loop insulin delivery during
nights with or without antecedent afternoon
exercise in type 1 diabetes
Sherr JL 1, Cengiz E 1, Palerm CC 2, Clark B 2, Kurtz N 2,
Roy A 2, Carria L1, Cantwell M 2, Tamborlane WV 1,
Weinzimer SA 1
1

Department of Pediatrics, Yale University School of
Medicine, New Haven, CT; and 2Medtronic Diabetes,
Northridge, CA

Diabetes Care 2013; 36: 2909–14

This manuscript is also discussed in article on Diabetes
Technology and Therapy in the Pediatric Age Group, p. S-103.
Background and Rationale
Individuals with type 1 diabetes often feel hesitant toward
engaging in physical activity (PA) due to the risk of postexercise hypoglycemia. A blunted epinephrine response makes
nocturnal hypoglycemia (NH) (7–11 h postexercise) particularly hazardous and common in youth who engage in afternoon
exercise (4). The aim of this study was to identify the frequency
of NH in a young population of individuals with well-managed
type 1 diabetes (T1D), who were using either standard openloop control (OL) or a closed-loop (CL) insulin delivery system, with or without exercise in the previous afternoon.
Methods
This randomized, crossover study design involved 12 male
and female subjects, 12–26 years of age, from the Yale T1D
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Program. Subjects were required to have a minimum of
1-year clinical diagnosis of T1D and to be utilizing insulin
pump therapy. On two separate occasions, subjects were
admitted for 48 h. One of the days was an exercise day in
which treadmill running was completed in the afternoon
(3 pm) at 50–55% of maximal effort. These exercise sessions
involved four 15 min bouts of physical activity with interspersed 5 min rest sessions. Intense physical activity was only
permitted during these times. The second admission day was
a sedentary resting day. The order of the days was randomized for each participant. On each of these 2-day admissions,
meal content and times were kept constant and snacks were
only allowed for the treatment of hypoglycemia. The OL
control involved patients adhering to their ‘‘usual care’’
routine, using their preferred glucose meter and insulin pump
from home with a new infusion set. Subjects determined their
own insulin boluses for meals and also made appropriate
modifications for exercise. The CL system involved two
continuous glucose sensors (Medtronic Sof-Sensor; one of
which served as a backup), a new insulin infusion set, a new
study pump (Medtronic Paradigm 715), and a ‘‘Medtronic
MiniLink REAL-Time transmitter adapted for 1 min transmission.’’ An algorithm was set up on the study computer
using 3–7 days of insulin usage data (Medtronic external PID
algorithm). Radiofrequency signals allowed communication
between the sensor and the pump. The algorithm’s target
glucose level was 120 mg/day during the day and at night.
Results
Both sedentary (OL 135 – 46 mg/dL vs. CL 140 – 47 mg/dL,
p = 0.02) and exercise (OL 141 – 63 vs. CL 147 – 56 mg/dL,
p = 0.04) conditions had lower 24 h mean blood glucose
levels during OL versus CL control, a difference that was
eliminated once readings < 70 mg/dL were disregarded.
During exercise, there were no differences in the number of
hypoglycemic episodes that required treatment between OL
and CL therapy. On the nights following sedentary days,
there was a greater percentage of BG values within the optimum 70–180 mg/dL range with CL control (98% CL vs.
87% OL), and fewer incidences of < 70 mg/dL BG readings
(4% OL vs. 1.5% CL, p < 0.0001), which correspond to 8
(OL) versus 3 (CL) cases. On nights following afternoon
exercise, OL treatment resulted in more hyperglycemic episodes and nocturnal low BG incidences increased by 11%
when compared with CL control. In absolute terms, postexercise nights had 23 versus 11 cases of < 70 mg/dL BG for
OL and CL, respectively ( p = 0.03). Across the entire experiment, OL control had 14 episodes of treatable NH
(< 60 mg/dL), whereas 2 episodes were seen on nights with
CL control ( p = 0.04). On nights after antecedent afternoon
exercise, there were 8 (in 4 subjects) versus 1 (in 1 subject)
cases of treatable NH episodes in OL versus CL control,
respectively. Regardless of the method of glycemic control
on exercise days, the majority of all NH cases took place
between 10 pm and 2 am. This corresponds to the 7–11 h
window predicted for postexercise hypoglycemia. Overall,
there was less insulin delivery and lower plasma insulin
levels on these nights with CL than with OL control (insulin
delivery: 0.8 – 1.09 units/h vs. 0.98 – 0.33 units/h, p = 0.008
and plasma insulin: 15.57 – 7.3 lU/mL vs. 17.06 – 6.76 lU/mL;
p = 0.06).
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Conclusion
CL control allowed for significantly lower incidences of
hypo-, treatable hypo-, and hyperglycemia during this experiment. Overnight glucose control during CL regulation on
sedentary days was well maintained, with more people in an
optimum range than in OL therapy. Moreover, the CL system
achieved better BG recordings, irrespective of antecedent
sedentary or exercise behavior. Facilitated by a feedback
control system, the number of cases of NH decreased with
lower insulin delivery between 10 pm and 2 am.
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whether a HR monitor can deliver the necessary information
regarding physical activity to a control-to-range (CTR) system to prevent hypoglycemia during exercise.
Methods

Adding heart rate signal to a control-to-range
artificial pancreas system improves the protection
against hypoglycemia during exercise
in type 1 diabetes

Twelve of 13 recruited adult subjects (aged 38 – 3.3 years
with a history of T1DM for 23.6 – 4.4 years) completed the
study. These individuals had been using insulin pumps for > 6
months and had glycated hemoglobin levels of 6.9% – 0.2%.
The experiment was composed of two back-to-back clinical
study stays, each being 24–26 h in length. Each afternoon of
admission involved a 30 min cycle ergometer exercise session
at an intensity of 9–10 on the Borg 20 point rating of perceived
exertion scale (i.e., moderate intensity aerobic exercise). The
same three meals were offered at every admission, with lunch
being served early to heighten the risk for hypoglycemia
during afternoon exercise. Prior to admission, subjects received two continuous glucose monitoring devices (Dexcom
SEVEN PLUS CGM) and a new insulin pump (Omnipod Insulin Management System, filled with Humalog insulin), and
were trained to use the Android-running DiAs portable AP
platform equipped with the appropriate algorithm. Subjects’
smartphones linked the actions of the CGM and insulin pump.
The control condition used only the CTR system, without inputting any measured HR data. In the experimental condition,
data from a HR monitor informed subjects to manually press
an ‘‘exercise button’’ whenever HR reached >125% of resting
HR (RHR). This activated the CTR + HR condition on the AP
system. Alternatively, when the HR was reduced to <125%
RHR, then the button was pressed again to return to sole CTR
control. The CTR algorithm is designed to predict alterations
in metabolic control and adjust insulin delivery accordingly.
The additional information provided by HR monitors allowed
the system to lessen insulin delivery, and do so at an earlier
time. Plasma glucose level was measured regularly to assess a
low blood glucose index (a numerical description of the risk
for hypoglycemia), the frequency of hypoglycemia (glucose
< 70 mg/dL, or sensation of hypoglycemia symptoms), the
percentage of time in euglycemia (70–180 mg/dL), and the
mean glucose level.

Breton MD, Brown SA, Karvetski CH, Kollar L,
Topchyan KA, Anderson SM, Kovatchev BP

Results

Comment
The results of this study showing better glycemic management with CL control, regardless of that day’s
physical activity status (sedentary/exercise), are promising. CL control will be particularly beneficial for youth
who do not necessarily adhere to a strict exercise regimen from day to day and who cannot forecast their exercise patterns. Rather than continuing with insulin basal
rates designed for sedentary times, regular feedback
control during exercise allows for an automated reduction in insulin delivery at hypoglycemia-vulnerable time
ranges. Reducing the risk of hypoglycemia can help
lessen the barrier to physical activity for youth with
T1D, making further optimization of this technology
extremely liberating and beneficial. Of course, these
promising CL results depend upon the entire setup
functioning correctly at all times—which the authors
acknowledge in their discussion. Moreover, a number of
safeguards (orthogonal sensors, implementation of rescue-glucagon doses) and improvements to existing
technology (algorithms for different types of exercise,
sensors, transmission systems, ease of patient use) are
likely needed to better prepare this system for home use.

Center for Diabetes Technology, University
of Virginia, Charlottesville, VA
Diabetes Technol Ther 2014; 16: 506–11

Background
Hypoglycemia risk is a major challenge for good glycemic
control in T1DM. Engaging in physical activity increases the
risk for repeated exposures to low BG levels, an impaired
counterregulatory response and ultimately hypoglycemiaassociated autonomic failure (HAAF). Exercise-induced
hypoglycemia can occur during exercise, or in early and late
recovery periods. Despite advancements in glycemic control
brought forth by the artificial pancreas (AP), the risk of hypoglycemia during and right after exercise persists because
of several physiological and technical challenges (5). A
heart rate (HR) monitor can relay data to a closed-loop system regarding physical activity status. This study assessed

The presence of HR monitor data allowed for smaller deviations from pre-exercise BG during exercise; the average
maximum BG change of - 29 mg/dL was seen with CTR
only and - 5 mg/dL with CTR + HR. There were, however,
no significant differences in average risk for hypoglycemia
during exercise and in the recovery period. The CTR + HR
group had an insignificant reduction in the frequency of hypoglycemia during exercise (none vs. 2; p = 0.16; effect
size = 0.45), during recovery (1 vs. 2; p = 0.56; effect size =
0.18), and overnight (none vs. one; p = 0.32; effect size 0.32),
and also an insignificant increase in time in normoglycemia
overall (81% – 3.9% vs. 75% – 4.3%), during exercise (91% –
7.3% vs. 85% – 10.3%), during recovery (86% – 9.3% vs.
84% – 7.9%), and overnight (89% – 7.1% vs. 84% – 9.2%)
compared to the control group. The CTR + HR group had
lower BG levels overall and during the overnight period,
whereas mean BG was unchanged during exercise and
recovery periods.
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Discussion
Using HR data, this portable AP system decreases the risk
for hypoglycemia during and after exercise by lowering insulin delivery once a predefined HR threshold is achieved.
Importantly, the protection against hypoglycemia was not at
the expense of hyperglycemia; average glucose was actually
lower, and still in the normoglycemic range.
Comment
As mentioned by the authors, the low power in this pilot
study (12 subjects) resulted in few measurements
reaching statistical significance. Nevertheless, it was
found that adding an HR monitor to the AP system is a
feasible implementation, and that further investigation
of this combined system for the protection against hypoglycemia during and after exercise is well warranted.
This is an important finding because HR monitors are
common and easy to use. Since the initiation of CTR +
HR control (i.e., when HR was >125% of RHR) was
manually inputted, it is difficult to account for potential
false alarms in the event that the HR monitor was actually linked to the DiAs platform. Furthermore, it is difficult to extend the results of this study to all patients
with T1D since the subjects were not at risk for cardiovascular events, nor were they on medications that
lowered HR, making the sample unrepresentative of all
T1DM patients. Nonetheless, incorporation of accelerometers into the setup as a measure of physical activity
could be one way to address this problem (6). Finally, it
is important to note that the results presented here are
only for mild exercise, and these protective effects
against hypoglycemia and hyperglycemia need to be
tested for other exercise modalities. In the future, a fully
automated system based on HR and perhaps other
physiological measures (temperature, accelerometry,
etc.) should make this technology a valuable way to
manage glucose levels during exercise.
Three 15-minute bouts of moderate postmeal
walking significantly improve 24 h glycemic
control in older people at risk for impaired
glucose tolerance
DiPietro J 1, Gribok A 2, Stevens MS 2, Hamm LF 1,
Rumpler W 2
1

Department of Exercise Science, George Washington
University of Public Health and Health Services,
Washington, DC; and 2Beltsville Human Nutrition Research
Laboratory, U.S. Department of Agriculture, Beltsville, MD
Diabetes Care 2013; 36: 3262–68

Background
Among other health risks, transient postmeal hyperglycemia can ultimately progress to type 2 diabetes. This is a
common occurrence in older adults, and the greatest extent of
damage is often done in isolated postprandial bouts of high
BG (7). Exercise can augment the effects of insulin on reducing BG levels, thereby providing an obvious effective
therapy. The purpose of this study was to determine the dif-
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ference between several smaller bouts of postmeal exercise
compared to one longer bout of exercise on postprandial and
24 h glucose control in older individuals.
Methods
Ten healthy male and female subjects at risk for impaired
glucose tolerance (fasting glucose 105–125 mg/dL), ‡ 60
years of age, were involved in this study. All subjects participated in a total of three different randomly ordered 2-day
protocols in a whole-room calorimeter, separated by 4 weeks.
The first 24 h of the protocol served as the sedentary control
day. The second day also involved inactivity, except for one
of three treadmill walking regimens: 15 min duration, done
30 min after eating each meal; 45 min duration, done at 10:30
am; 45 min duration, done at 4:30 pm. All exercise was
performed under supervision at 3 metabolic equivalent of
task (METs [MET value = VO2(mL (kg min) - 1)/3.5]), as
previously calculated by a treadmill test. CGM data allowed
for analysis of 24 h average glucose concentrations, average
3 h postlunch glucose concentrations, and average 3 h postdinner glucose concentrations.
Results
There was a reduced insulin response in the middle of the
day as levels of this hormone significantly decreased after
each subsequent meal (postlunch: 37.9 – 33.4 vs. postbreakfast: 59.4 – 53.5 lU/mL; p < 0.001 & predinner: 7.4 – 3.4 vs.
prelunch: 14.2 – 13.4 lU/mL; p < 0.001). Changes in 0–30 min
postprandial insulin levels declined as the day progressed;
values were 60% after breakfast, 40% after lunch, and 54%
after dinner ( p < 0.01). Postmeal exercise prevented additional rises in postprandial glucose values and this was most
prominent after 6 pm, and these postdinner exercise benefits lasted until 7 am the following morning. The favorable
decrease in average 24 h glucose concentrations were comparable between three bouts of 15 min walking sessions
(-10%, p < 0.03) and one morning 45 min walk (-8%,
p < 0.05) compared to control conditions. 45 min afternoon
exercise resulted in no significant difference in average 24 h
glycemia. Postmeal exercise was the only protocol that
lowered the 3 h glucose response to dinner compared to the
control day. One 45 min bout of morning exercise had no
effect on postdinner glucose, and sustained afternoon walking (predinner) increased the 3 h elevation in glucose associated with dinner when compared with the control day. A
correlation was found between 24 h glycemia amelioration
and better 3 h postdinner values (r = 0.88; p < 0.001).
Conclusion
This study demonstrated that the timing and frequency of
exercise can impact the glycemic response as the volume and
intensity of exercise was kept constant under all protocols
(45 min/day at 3.0 METS). There were a number of benefits
associated with a 15 min walk done soon after a meal: it
lowered 24 h glucose concentrations to a level that was
comparable to one sustained 45 min bout of morning walking, and it was the only exercise protocol that improved 3 h
postdinner glucose values. The correlation between improvements in both 24 and 3 h postdinner glucose values
indicates that walking after dinner could be a beneficial
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activity in the betterment of overall daily glucose homeostasis. This is an important finding because such smaller
doses of frequently performed low-moderate intensity
exercise sessions can result in better adherence in older
individuals.
Comment
This study showed that simply walking for 15 min soon
after a meal results in marked improvements in glycemia
in older persons at risk for glucose intolerance. Given the
prevalence and high number of health complications
associated with glycemic dysregulation and with aging,
it is of extreme importance to find simple cost-effective
solutions that are not considered too onerous for the
older patient. As mentioned by the authors, an exercise
intensity of 3.0 METS (a mild walk) aligns with what is
recommended for older adults (8), and this study shows
that even short walks, perhaps while completing daily
chores, can improve glycemic control as good or better
than prolonged activity. By providing exercise prescriptions that are cost-effective, accessible, and less
intimidating to older individuals, healthcare providers
facilitate the development of self-efficacy in their patients, thereby increasing the likelihood of long-term
adherence and health benefits.
Changes in physical performance in older
women according to presence and treatment
of diabetes mellitus
1–3

4

4

3

Lee CG , Schwartz AV , Yaffe K , Hillier TA , LeBlanc
ES 3, Cawthon PM 5, for the Study of Osteoporotic
Fractures Research Group
1

Research Service, Veterans Affairs Medical Center,
Portland, OR; 2Department of Medicine, Oregon Health &
Science University, Portland, OR; 3Center for Health
Research, Kaiser Permanente Northwest, Portland, OR;
4
Department of Epidemiology and Biostatistics, University
of California at San Francisco, San Francisco, CA; and
5
California Pacific Medical Center Research Institute, San
Francisco, CA
J Am Geriatr Soc 2013; 61: 1872–78

Background
Older adults with diabetes mellitus (DM) are at risk of
having falls while carrying out the activities of daily living (9).
One way to prevent or treat the risk associated with functional
decline is to assess measures of physical performance to find
the reasons for physical impairment in individuals with DM.
This longitudinal study analyzed grip strength and walking
speed in a group of older women to assess whether DM and/or
the use of the insulin sensitizers (IS) affect the changes in
physical performance that accompany aging.
Methods
A cohort of 2,864 Caucasian and African American
women >65 years of age who were initially involved in the
prospective study of osteoporotic fractures were examined
on two occasions, spaced 4–7 years apart. DM status or

medication use was self-reported, and medications were
brought to the research clinic for documentation. Metformin
or thiazolidinediones were the only categorized IS. Each
visit involved the averaging of two trials in which subjects
were timed as they walked 6 m at their usual gait speed
(usual gait), and rapid gait speed (rapid gait), and also
completed two trials on a dynamometer in each hand (grip
strength). Questionnaires were also used to account for other
drugs, socioeconomic status, and additional health markers
and behaviors.
Results
Women with DM had insignificantly higher grip strength
(DM: 18.5 – 4.8; no DM: 17.9 – 4.2 kg; p = 0.08), but slower
usual (DM: 0.90 – 0.18; no DM: 0.96 – 0.18; p < 0.001) and
rapid gait (DM: 1.15 – 0.25; no DM: 1.24 – 0.25; p < 0.001)
speed when compared to nondiabetic women. Throughout
the study period (*5 years), a greater decline in usual and
rapid walking speed was seen in women with DM compared
to women who did not have DM. There was no difference in
the loss of grip strength with time between these two groups.
Women with DM taking IS (particularly those taking metformin) had less decline in usual walk speed than those not
taking IS. Walking regularly did not significantly alter
physical performance in the women in the study.
Discussion
While DM status did not result in a difference in grip
strength losses, women with DM had more of a decline in
walk speed compared to women without DM. The use of IS in
women with DM led to a smaller drop in usual walk speed
than women with DM who did not take IS. The greater
functional losses in the lower versus upper extremities are
important to note because maintenance of lower body
strength is of greater importance when aiming to prevent falls
and mobility problems.
Comment
This study is important because it emphasizes the need to
measure functional outcomes and use such measurements to establish ways in which potential injuries for
individuals with DM can be recognized and prevented.
The use of IS, and in particular metformin, appeared to
help attenuate the reduction in walking speed, perhaps
by improving muscle function and/or by improving
cognitive function and micro- and macrovascular health.
As noted by the authors, the generalization and reliability of some results may be difficult to predict because
this was a cohort of relatively healthy individuals involved in a longitudinal study with much of the data
collected via questionnaires. Nevertheless, the use of IS,
particularly metformin, to combat the age-associated
decline in physical performance measures can be one
way older individuals can combat the risk of mobility
problems. An attenuated decline in gait speed may allow
the elderly to remain confident in their functional capabilities, thereby promoting continual engagement in
healthy living.

ADVANCES IN EXERCISE, PHYSICAL ACTIVITY, AND DIABETES MELLITUS
Feasibility of a portable bihormonal closed-loop
system to control glucose excursions at home
under free-living conditions for 48 hours
van Bon AC 1, Luijf YM1, Koebrugge R 2, Koops R 2,
Hoekstra JBL 1, DeVries JH 1
1

Department of Internal Medicine, Academic Medical
Centre, Amsterdam, the Netherlands; and 2Inreda Diabetic
B.V., Goor, the Netherlands

Discussion
This study showed that a bihormonal CL system is feasible
at home with comparable time spent in euglycemia as OL
control and a significantly lower median glucose levels by
day 2 of use. The reduction in median glucose levels on day 2
of use does come at the expense of more time in hypoglycemia, however.
Comment
This study should be considered a major technological
breakthrough since it brings the bihormonal AP home
from the research setting. One of the challenges in this
study was the elevated number of hypoglycemic episodes during the second day of CL control. The authors
comment that this was possibly due to CGM problems.
Similarly, technical issues regarding cable and wireless
connections between the devices used in this study
highlight the importance of optimizing the setup for
faultless functioning, perhaps via incorporation of multiple system parts into one device. While there is work to
be done on the technical, safety, and practical size of the
device, CL control is beginning to demonstrate improvements in control over OL systems. Implementation
of a bihormonal system, in tandem with removing the CL
setup outside of the research lab and into the home setting, takes us all a step forward in advancing this technology for home use.

Diabetes Technol Ther 2014; 16: 131–36

Background
This study aimed to remove a current closed-loop (CL)
glucose control system from the clinical research setting and
test it for 48 h while subjects led their typical lifestyles at
home.
Methods
In this crossover study, 11 subjects with T1D using continuous subcutaneous insulin infusion for > 6 months were
analyzed. The experiment was designed to compare openloop (OL) and fully automated bihormonal (insulin and
glucagon) CL glycemic control systems that received no
manual exercise or mealtime notices. First, under OL control,
the CGMS System Gold Medtronic MiniMed was inserted, and subjects administered insulin as per their usual
care. After a minimum of 3 weeks, under CL control, and
after a 12 h optimization period in the research center, subjects carried on with their desired routine for 48 h, at or
around their home. These subjects wore 2 D-Tron + pumps
for automated subcutaneous insulin and glucagon administration and 2 Medtronic CGM sensors. These tools were
linked to a personal computer running the algorithm software. The algorithm’s insulin sensitivity parameter was dependent on the rise and fall of postprandial glucose levels.
Preset boluses of insulin and glucagon were given if BG did
not remain at optimal levels (*6.5 mmol/L). Hypoglycemia
was defined as a BG reading <3.5 mmol/L at which point an
alarm alerted the subject to eat supplemental carbohydrates
(CHO). The system was also equipped with other warnings
(high glucose, pump occlusion alert, etc.). The main measurement of the study was to compare OL to CL control with
respect to the amount of time in euglycemia (3.9–10 mmol/L)
on a given experimental day (day 1 or 2).
Results
The amount of supplemental CHO needed, total insulin
infused, and time spent in euglycemia and in hyperglycemia
were similar between OL and CL control; however, the median time spent in hypoglycemia was significantly higher on
the second day with CL than OL (2.8% vs. 0%). Similarly,
median glucose level was also lower on day 2 and during the
night of day 2 with CL compared to OL control. Among other
minor technical problems (occlusion alerts, high glucose
alert, loss of wireless connection, etc.), the backup sensor was
needed 16 times in CL control. There was, however, a significantly greater amount of median time spent in eugylcemia
on the first day of CL control (97.1%) compared to OL
control (69%).
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Hypoglycemia begets hypoglycemia:
the order effect in the ASPIRE in-clinic study
Garg SK 1, Brazg RL 2, Bailey TS 3, Buckingham BA 4,
Slover RH 1, Klonoff DC 5, Shin J 6, Welsh JB 6,
Kaufman FR 6
University of Colorado Denver, Aurora, CO; 2Rainier
Clinical Research Center, Renton, WA; 3AMCR Institute,
Escondido, CA; 4Stanford University, Stanford, CA;
5
Mills-Peninsula Health Services, San Mateo, CA;
and 6Medtronic, Inc., Northridge, CA
1

Diabetes Technol Ther 2014; 16: 125–30

Background
Repetitive cases of hypoglycemia can lead to hypoglycemia-associated autonomic failure (HAAF). As an alternative
to continued basal insulin delivery, as demonstrated recently
in the ASPIRE-in-clinic study (10), automatic pump suspension at a predefined glucose threshold reduces the risk of
hypoglycemia and does not promote rebound hyperglycemia
in patients with T1D. The purpose of this study was to assess
how antecedent hypoglycemia affects CSII threshold suspension (TS) technology.
Methods
This study examined 50 T1D subjects who exercised
until plasma glucose reached £ 85 mg/dL (YSI analyzer)
and then rested, and hypoglycemia was evaluated after
the plasma glucose was < 70 mg/dL. In TS experiments,
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insulin was automatically suspended for 2 h once the
sensor glucose (SG) reached a threshold of £ 70 mg/dL; in
control experiments, basal insulin delivery continued.
Subjects were randomly assigned to Group A (TS in period
1; control in period 2) or Group B (control in period 1; TS
in period 2). This experiment had a crossover design with a
3–10-day washout period between trials. The primary
measurements of the study were hypoglycemia duration
(time between 50–70 mg/dL) and severity (lowest BG
value observed). To ensure subjects’ safety, the experiment was stopped if a YSI glucose value exceeded 300 or
decreased below 50 mg/dL.
Results
Hypoglycemia duration was shorter (107.8 – 71.2 min in
period 1 vs. 171.5 – 67.0 min in period 2; p < 0.01), recovery from low BG was faster, and glucose values were
higher when TS control took place in period 1 (P1TS)
rather than in period 2 (P2TS). The total duration of hypoglycemia preceding P1TS was significantly lower than
P2TS (16.6 min vs. 204.6 min; p < 0.001). Period 1 did not
follow a phase of continued insulin delivery, but could
come after a previously terminated experiment (BG
< 50 mg/dL). On the other hand, period 2 followed at least
1 former control period in which basal insulin continued to
be delivered despite low BG. The control condition had a
4 h observation period in which subjects were hypoglycemic for the whole time, and there was no difference
whether the control time was in P1 or P2. The percentage
of subjects who were hypoglycemic was less during P1TS
compared to P2TS.
Discussion
This study showed that recent bouts of hypoglycemia make
it more difficult to recover from future hypoglycemic episodes even when TS is used. In period 1, in which patients
had not had antecedent hypoglycemia, TS resulted in rapid
normalization of BG levels when hypoglycemia occurred.
Although the technology was still effective when recent hypoglycemia was initiated using exercise, the time and depth
of duration was higher. The authors conclude that the effect
of antecedent hypoglycemia should be taken into consideration in the design of future experiments assessing strategies
to limit hypoglycemia.
Comment
This study highlights the importance of avoiding severe, prolonged episodes of hypoglycemia and the
self-propagating cycle of glycemic dysregulation (i.e.,
‘‘hypoglycemia begets hypoglycemia’’). One should
consider that a previous bout of exercise that promotes
mild hypoglycemia makes TS technology less able to
mitigate recovery hypoglycemia, unless the predefined
thresholds are elevated. As the authors point out in their
discussion, the implementation of the TS system immediately following a bout of hypoglycemia may help individuals with T1D speed up recovery from low BG and
thereby better protect themselves from developing HAAF.
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Background
Both rodent and human studies suggest that excess fructose
(sugar/high-fructose corn syrup) can lead to a myriad of
metabolic conditions, including type 2 diabetes, in part due to
their ability to impact liver function (11). Among other
benefits, exercise is known to improve lipid profiles such as
reducing triglyceride-rich lipoprotein (TRL) and triglycerides (TG) levels in both lean and obese individuals (12). This
study sought to examine whether exercise could improve the
negative metabolic effects of a high-fructose diet.
Methods
Eight sedentary, healthy, nonobese males, aged 21.5 – 2.7
years, were involved in this crossover study. Subjects
were studied on 3 separate 4-day protocols: low-fructose
weight-maintenance diet, and no exercise (control); weight
maintenance diet with high-fructose (30%) served as lemonflavored beverages, and no exercise [HFr]; and high-fructose
(30%) diet plus 30 min of cycling exercise at 125 W power
output at 12 and 5 pm every day [HFrEx]. Oral fructose tests
[13C] were conducted on the 5th day of each protocol.
Results
The HFr sedentary protocol led to a significantly elevated plasma TG, TRL-TG, apolipoprotein B48 (apob48),
and glucose concentrations compared to the control group
( p < 0.05). Exercise significantly decreased all of these
changes compared to the HFr group, except fasting plasma
glucose concentrations. Furthermore, the HFrEx group had
reduced small LDL particles compared to control, and increased LDL-1 and b-hydroxybutyric acid (BHB) compared
to HFr. During oral fructose loading, the HFr trial resulted in
elevated postload total TG, TRL-TG, [13C]TRL-palmitate,
and glucose concentrations, but decreased NEFA concentrations and lowered clearance of TRL-TG. With HFrEx,
postprandial levels of total TG, TRL-TG, and [13C] TRLpalmitate concentrations were all comparable to the control
group and TRL-TG clearance increased by 66% in comparison to the HFr trial. HFrEx subjects also had higher
nonesterified fatty acids (NEFA) and glycerol concentrations
compared with both control and HFr, decreased insulin
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concentrations and CHO oxidation, and increased net lipid
oxidation. Energy expenditure in the HFrEx group was only
higher compared to the control group, not the HFr group.
Discussion
High levels of fructose, alongside a weight-maintenance
diet, negatively affects blood lipids, and exercise can ameliorate these alterations. In the HFrEx trial, harmful lipid
parameters induced in the HFr condition were normalized.
Comment
Given the high prevalence of fructose in the North
American diet, it is important to understand the metabolic consequences of such consumption. As the authors
mention, it should be noted that the average American
has a fructose intake that is *10% of their diet (13),
making it likely that the study’s daily 30% load overexaggerated the effects of this sugar on the body. Since
each individual trial was of shorter duration, future experiments analyzing the cumulative effects of long-term
fructose intake on lipid metabolism, with or without
regular exercise, would be beneficial. Of great relevance
to individuals with impaired lipid profiles or those at risk
for type 2 diabetes, exercise can serve as a viable therapeutic to lower the negative metabolic parameters induced by high-fructose feeding. Further research can
provide insight into the optimum dose of exercise that
ameliorates such effects.
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